A New Classification System to Predict Functional Outcome after Laryngectomy and Laryngopharyngectomy
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Cohort
2.2. The Vienna Laryngopharyngectomy Classification System
2.3. Functional Endpoints
2.4. Complications
2.5. Statistical Methods
3. Results
3.1. Patient Population
3.2. Surgical Ablation
3.3. Reconstruction
3.4. Complications According to the Proposed Classification System
3.5. Pharyngocutaneous Fistula
3.6. Functional Outcome
3.7. Swallowing
3.8. Temporary Gastrostomy Tube Dependence
3.9. Pharyngeal Stenosis
3.10. Oral Nutrition
3.11. Voice Rehabilitation
3.12. Functional Outcome According to the Classification System
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wolf, G.T.; Fisher, S.G.; Hong, W.K.; Hillman, R.; Spaulding, M.E.; Laramore, G.; Endicott, J.W.; McClatchey, K.; Henderson, W.G. The department of veterans affairs laryngeal cancer study group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 1991, 324, 1685–1690. [Google Scholar] [CrossRef]
- Forastiere, A.A.; Ismaila, N.; Lewin, J.S.; Nathan, C.A.; Adelstein, D.J.; Eisbruch, A.; Fass, G.; Fisher, S.G.; Laurie, S.A.; Le, Q.-T.; et al. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical practice guideline update. J. Clin. Oncol. 2018, 36, 1143–1169. [Google Scholar] [CrossRef] [PubMed]
- Bozec, A.; Culié, D.; Poissonnet, G.; Dassonville, O. Current role of total laryngectomy in the era of organ preservation. Cancers 2020, 12, 584. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Babin, E.; Blanchard, D.; Hitier, M. Management of total laryngectomy patients over time: From the consultation announcing the diagnosis to long term follow-up. Eur. Arch. Oto Rhino Laryngol. 2011, 268, 1407–1419. [Google Scholar] [CrossRef] [PubMed]
- Forastiere, A.A.; Goepfert, H.; Maor, M.; Pajak, T.F.; Weber, R.; Morrison, W.; Glisson, B.; Trotti, A.; Ridge, J.A.; Chao, C.; et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 2003, 349, 2091–2098. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tassler, A.B.; Ms, W.E.G.; Ferris, R.L. Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit? Head Neck 2019, 41, 2167–2173. [Google Scholar] [CrossRef] [PubMed]
- Hasan, Z.; Dwivedi, R.; Gunaratne, D.; Virk, S.; Palme, C.; Riffat, F. Systematic review and meta-analysis of the complications of salvage total laryngectomy. Eur. J. Surg. Oncol. 2017, 43, 42–51. [Google Scholar] [CrossRef]
- Megwalu, U.C.; Sikora, A.G. Survival outcomes in advanced laryngeal Cancer. JAMA Otolaryngol. Neck Surg. 2014, 140, 855–860. [Google Scholar] [CrossRef] [Green Version]
- Parzefall, T.; Wolf, A.J.; Czeiger, S.; Frei, K.; Formanek, M.; Erovic, B.M. Effect of postoperative use of diclofenac on pharyngocutaneous fistula development after primary total laryngopharyngectomy: Results of a single-center retrospective study. Head Neck 2016, 38, E1515–E1520. [Google Scholar] [CrossRef]
- Parzefall, T.; Wolf, A.; Grasl, S.; Altorjai, G.; Czeiger, S.; Grasl, M.C.; Erovic, B.M. Post-laryngectomy adjuvant radiotherapy in patients with pharyngocutaneous fistulae: Treatment regimens, outcomes and complications in 67 patients. Clin. Otolaryngol. 2019, 44, 810–814. [Google Scholar] [CrossRef]
- Baijens, L.W.J.; Walshe, M.; Aaltonen, L.-M.; Arens, C.; Cordier, R.; Cras, P.; Crevier-Buchman, L.; Curtis, C.; Golusinski, W.; Govender, R.; et al. European white paper: Oropharyngeal dysphagia in head and neck cancer. Eur. Arch. Oto Rhino Laryngol. 2021, 278, 577–616. [Google Scholar] [CrossRef] [PubMed]
- Rütten, H.; Pop, L.A.; Janssens, G.O.; Takes, R.P.; Knuijt, S.; Rooijakkers, A.F.; Berg, M.V.D.; Merkx, M.A.; Van Herpen, C.M.; Kaanders, J.H. Long-Term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: Results of a multidisciplinary late morbidity clinic. Int. J. Radiat. Oncol. 2011, 81, 923–929. [Google Scholar] [CrossRef]
- Charlson, M.E.; Pompei, P.; Ales, K.L.; MacKenzie, C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987, 40, 373–383. [Google Scholar] [CrossRef]
- Clark, J.R.; Gilbert, R.; Irish, J.; Brown, D.; Neligan, P.; Gullane, P.J. Morbidity after flap reconstruction of hypopharyngeal defects. Laryngoscope 2006, 116, 173–181. [Google Scholar] [CrossRef] [PubMed]
- Murray, D.J.; Novak, C.B.; Neligan, P.C. Fasciocutaneous free flaps in pharyngolaryngo-oesophageal reconstruction: A critical review of the literature. J. Plast. Reconstr. Aesthetic Surg. 2008, 61, 1148–1156. [Google Scholar] [CrossRef] [PubMed]
- Robinson, R.A.; Simms, V.A.; Ward, E.C.; Barnhart, M.K.; Chandler, S.J.; Smee, R.I. Total laryngectomy with primary tracheoesophageal puncture: Intraoperative versus delayed voice prosthesis placement. Head Neck 2017, 39, 1138–1144. [Google Scholar] [CrossRef] [PubMed]
- Worley, M.L.; Graboyes, E.M.; Blair, J.; Momin, S.; Day, T.A.; Hornig, J.D.; Skoner, J.; Huang, A.T. Factors associated with gastrostomy tube dependence following salvage total laryngectomy with microvascular free tissue transfer. Head Neck 2019, 41, 865–870. [Google Scholar] [CrossRef]
- Farlow, J.L.; Birkeland, A.C.; Hardenbergh, A.; Lyden, T.; Brenner, J.C.; Shuman, A.G.; Chinn, S.B.; Stucken, C.L.; Malloy, K.M.; Moyer, J.S.; et al. Speech and swallowing outcomes after laryngectomy for the dysfunctional irradiated larynx. Eur. Arch. Oto-Rhino Laryngol. 2020, 277, 1459–1465. [Google Scholar] [CrossRef]
- Deschler, D.G.; Bunting, G.W.; Lin, D.T.; Emerick, K.; Rocco, J. Evaluation of voice prosthesis placement at the time of primary tracheoesophageal puncture with total laryngectomy. Laryngoscope 2009, 119, 1353–1357. [Google Scholar] [CrossRef]
- Meulemans, J.; Demarsin, H.; Debacker, J.; Batailde, G.; Mennes, T.; Laenen, A.; Goeleven, A.; Neyt, P.; Vanclooster, C.; Vauterin, T.; et al. Functional outcomes and complications after salvage total laryngectomy for residual, recurrent, and second primary squamous cell carcinoma of the larynx and hypopharynx: A multicenter retrospective cohort study. Front. Oncol. 2020, 10. [Google Scholar] [CrossRef]
- Schuman, A.D.; Birkeland, A.C.; Farlow, J.L.; Lyden, T.; Blakely, A.; Spector, M.E.; Rosko, A.J. Predictors of stricture and swallowing function following salvage laryngectomy. Laryngoscope 2020. [Google Scholar] [CrossRef] [PubMed]
Overall | Primary | Salvage | ||
---|---|---|---|---|
Variables | n (%) | n (%) | n (%) | p-Value |
Sex | 258 (100) | 161 (62.4) | 97 (37.6) | |
Female | 28 (10.9) | 16 (9.9) | 12 (12.4) | |
Male | 230 (89.1) | 145 (90.1) | 85 (87.6) | 0.543 a |
Age (mean ± SD) | 59.2 ± 9.2 | 58.5 ± 9.2 | 60.4 ± 9.1 | 0.103 b |
Charlson Comorbidity Index | 2.3 ± 1.8 | 2.2 ± 1.7 | 2.4 ± 1.7 | 0.334 b |
Smoking | ||||
No history of smoking | 49 (19) | 27 (16.8) | 22 (22.7) | |
Active smoker | 153 (59.3) | 109 (67.7) | 44 (45) | |
Former smoker | 56 (21.7) | 25 (15.5) | 31 (32) | 0.001a |
Primary Tumor Site | ||||
Larynx | 138 (53.5) | 86 (53.4) | 52 (53.6) | |
Hypopharynx | 120 (46.5) | 75 (46.6) | 45 (46.4) | 0.976 a |
T-Stage * | ||||
T1 | 10 (3.9) | 5 (3.1) | 5 (5.2) | |
T2 | 33 (12.8) | 18 (11.2) | 15 (15.5) | |
T3 | 88 (34.1) | 65 (40.4) | 23 (23.7) | |
T4a | 117 (45.3) | 74 (44.1) | 46 (47.4) | 0.093 a |
N-Stage * | ||||
N0 | 125 (48.4) | 57 (35.4) | 68 (70.1) | |
N1 | 22 (8.5) | 14 (8.7) | 8 (8.2) | |
N2 | 91 (35.3) | 81 (48.4) | 13 (13.4) | |
N3 | 10 (3.9) | 10 (6.2) | 0 (0.0) | <0.001a |
Indication for TL | ||||
Primary Tumor | 151 (58.5) | 147 (91.3) | 4 (4.1) | |
Recurrence | 89 (34.5) | 11 (6.8) | 78 (80.4) | |
Residual Tumor | 11 (4.3) | 3 (1.8) | 8 (8.2) | |
Dysfunctional Larynx | 7 (2.7) | 0 (0.0) | 7 (7.2) | <0.001a |
Type of Surgery | ||||
TL | 85 (32.2) | 61 (37.9) | 24 (24.7) | |
TLPP | 101 (39.1) | 63 (39.1) | 38 (39.2) | |
TLTP | 72 (27.9) | 37 (23) | 35 (36.1) | 0.032a |
Laryngectomy | Laryngectomy with Partial Pharyngectomy | Laryngectomy with Total Pharyngectomy | |||||
---|---|---|---|---|---|---|---|
IA | IB | IIA | IIB | IIIA | IIIB | ||
Variables | n (%) | n (%) | n (%) | p | |||
Used Flaps | |||||||
SAFF | 0 (0) | 0 (0) | 0 (0) | 8 (22.9) | 2 (4.8) | 1 (2.4) | |
ALT | 0 (0) | 0 (0) | 0 (0) | 1 (2.9) | 2 (4.8) | 4 (9.5) | |
RFFF | 0 (0) | 0 (0) | 1 (11.1) | 0 (0) | 0 (0) | 0 (0) | |
Jejunum | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 31 (73.8) | 10 (23.8) | |
Jejunum + PMMF | 1 (16.7) | 1 (5.9) | 1 (11.1) | 1 (2.9) | 1 (2.4) | 16 (38.1) | |
RFFF+ PMMF | 0 (0) | 0 (0) | 0 | 0 (0) | 0 (0) | 3 (7.1) | |
PMMF | 5 (83.3) | 16 (94.1) | 7 (77.8) | 25 (71.4) | 6 (14.3) | 8 (19.1) | |
Salivary tube * | |||||||
No | 57 (93.4) | 19 (79.2) | 58 (92.1) | 23 (60.5) | 35 (94.6) | 25 (71.4) | |
Yes | 1 (1.6) | 5 (20.8) | 1 (1.6) | 14 (36.8) | 2 (5.4) | 8 (22.9) | <0.001 a |
Complications | |||||||
No | 50 (82) | 19 (79.2) | 45 (71.4) | 21 (55.3) | 26 (70.3) | 15 (42.9) | |
Yes | 11 (18) | 5 (20.8) | 18 (28.6) | 17 (44.7) | 11 (29.7) | 20 (57.1) | 0.001 a |
Bleeding | 4 (36.4) | 1 (20) | 1 (5.6) | 6 (35.3) | 3 (27.3) | 5 (25) | |
Wound healing | 1 (9.1) | 1 (20) | 8 (44.4) | 2 (11.8) | 0 (0) | 2 (10) | |
Infection | 0 (0) | 1 (20) | 2 (11.1) | 0 (0) | 2 (18.2) | 0 (0) | |
Hematoma; Chyle; Seroma | 4 (36.4) | 2 (40) | 5 (27.8) | 5 (29.4) | 1 (9.1) | 1 (5) | |
Stroke; CPR; Heart attack | 2 (18.2) | 0 (0) | 2 (11.1) | 0 (0) | 0 (0) | 0 (0) | |
Donor site | 0 (0) | 0 (0) | 0 (0) | 1 (5.9) | 2 (18.2) | 6 (30) | |
Flap failure | 0 (0) | 0 (0) | 0 (0) | 1 (5.9) | 1 (9.1) | 4 (20) | |
Combined | 0 (0) | 0 (0) | 0 (0) | 2 (11.8) | 2 (18.2) | 2 (10) | 0.005 a |
Surgical complications | 9 (14.8) | 4 (16.7) | 14 (22.2) | 17 (44.7) | 9 (24.3) | 21 (60) | |
General complications | 2 (3.3) | 1 (4.2) | 4 (6.3) | 0 (0) | 4 (10.8) | 2 (5.7) | 0.001 a |
Revision/Follow-up surgeries | |||||||
No | 52 (85.2) | 17 (70.8) | 51 (81) | 25 (65.8) | 27 (73) | 17 (48.6) | |
Yes | 9 (14.8) | 7 (29.2) | 12 (19) | 13 (34.2) | 10 (27) | 18 (51.4) | 0.002 a |
PCF | |||||||
No | 47 (77) | 16 (66.7) | 43 (68.3) | 21 (55.3) | 23 (62.2) | 23 (65.7) | |
Yes | 14 (23) | 8 (33.3) | 20 (31.7) | 17 (44.7) | 14 (37.8) | 12 (34.3) | 0.345 a |
≤30 days | 11 (18) | 6 (25) | 18 (28.6) | 16 (42.1) | 7 (18.9) | 9 (25.7) | 0.139 a |
>30 days | 3 (5) | 2 (8.3) | 2 (3.1) | 1 (2.6) | 7 (18.9) | 3 (8.6) | 0.047 a |
Persistent | 0 (0) | 0 (0) | 2 (10) | 3 (17.6) | 5 (35.7) | 7 (58.3) | 0.001 a |
Univariate Analysis | |||
---|---|---|---|
Variables | OR | p-Value | 95% CI |
Sex (Female) | 2.24 | 0.046 | 1.01–4.94 |
Age (≤60 a) | 0.88 | 0.632 | 0.52–1.48 |
Preoperative BMI (≤24.2) | 1.21 | 0.588 | 0.60–2.47 |
Comorbidity Index (≤2.0) | 0.90 | 0.707 | 0.53–1.54 |
Tumor site (Larynx) | 0.75 | 0.388 | 0.38–1.45 |
T1–T2 vs. T3–T4a | 1.28 | 0.485 | 0.64–2.53 |
N− vs. N+ | 0.88 | 0.621 | 0.51–1.49 |
Free Flap (No) | 0.64 | 0.110 | 0.37–1.10 |
Pharynx reconstruction (No) | 0.73 | 0.261 | 0.42–1.23 |
No reconstruction with jejunum | 2.11 | 0.105 | 0.85–5.18 |
Pharyngeal closure (unilayer) | 1.13 | 0.699 | 0.62–2.05 |
Pharyngeal closure (T-form) | 1.12 | 0.720 | 0.61–2.03 |
Salivary tube (No) | 0.54 | 0.116 | 0.25–1.16 |
Non-Salvage Surgery | 0.69 | 0.169 | 0.41–1.17 |
PORT (No) | 1.44 | 0.174 | 0.85–2.42 |
Class. (continuous) | 1.14 | 0.094 | 0.98–1.33 |
Complications (No) | 0.79 | 0.396 | 0.45–1.37 |
Univariate Analysis | Multivariate Analysis | |||||
---|---|---|---|---|---|---|
Complete Oral Nutrition | OR | p-Value | 95% CI | OR | p-Value | 95% CI |
Sex (Female) | 0.60 | 0.322 | 0.22–1.65 | |||
Age (≤60 a) | 0.74 | 0.389 | 0.37–1.47 | |||
Preoperative BMI (≤24.2) | 0.58 | 0.140 | 0.28–1.19 | |||
Comorbidity Index (≤2.0) | 0.62 | 0.202 | 0.30–1.29 | |||
Tumor site (Larynx) | 1.84 | 0.082 | 0.89–3.51 | |||
T1-T2 vs. T3-T4a | 1.36 | 0.547 | 0.50–3.64 | |||
N- vs. N+ | 1.82 | 0.099 | 0.89–3.72 | |||
Pharynx reconstruction (No) | 4.72 | <0.001 | 2.25–9.91 | 4.44 | 0.042 | 1.05–18.71 |
Salivary tube (No) | 1.53 | 0.383 | 0.59–3.98 | |||
Salvage surgery (No) | 2.42 | 0.015 | 1.19–4.94 | 1.97 | 0.134 | 0.81–4.76 |
PORT (No) | 0.65 | 0.224 | 0.33–1.30 | |||
Class. (continuous) | 0.63 | <0.001 | 0.50–0.79 | 0.99 | 0.945 | 0.64–1.53 |
PCF (No) | 3.13 | 0.002 | 1.54–6.37 | 3.29 | 0.003 | 1.49–7.28 |
Short-term complications (No) | 3.56 | 0.001 | 1.68–7.55 | 3.47 | 0.004 | 1.48–8.14 |
G-Tube Dependence | ||||||
Sex (Female) | 4.31 | 0.013 | 1.36–13.66 | 2.06 | 0.291 | 0.54–7.88 |
Age (≤60 a) | 1.53 | 0.361 | 0.62–3.81 | |||
Preoperative BMI (≤ 24.2) | 2.48 | 0.085 | 0.88–6.96 | |||
Comorbidity Index (≤ 2.0) | 1.55 | 0.375 | 0.59–4.04 | |||
Tumor site (Larynx) | 0.27 | 0.006 | 0.11–0.69 | 0.68 | 0.541 | 0.20–2.33 |
T1-T2 vs. T3-T4a | 1.96 | 0.216 | 0.68–5.68 | |||
N- vs. N+ | 0.60 | 0.280 | 0.24–1.51 | |||
Pharyngeal reconstruction (No) | 0.21 | 0.001 | 0.08–0.53 | 0.84 | 0.849 | 0.15–4.90 |
Salivary tube (No) | 0.51 | 0.245 | 0.16–1.59 | |||
Salvage surgery (No) | 0.42 | 0.061 | 0.17–1.04 | |||
PORT (No) | 1.56 | 0.330 | 0.64–3.84 | |||
Class. (continuous) | 1.77 | <0.001 | 1.30–2.40 | 1.48 | 0.222 | 0.79–2.78 |
PCF (No) | 0.20 | 0.001 | 0.08–0.51 | 0.21 | 0.004 | 0.07–0.60 |
Short-term complications (No) | 0.30 | 0.011 | 0.12–0.76 | 0.37 | 0.075 | 0.12–1.10 |
Pharyngeal Stenosis | ||||||
Sex (Female) | 4.81 | 0.003 | 1.69–13.72 | 3.56 | 0.074 | 0.88–15.02 |
Age (≤60 a) | 1.18 | 0.660 | 0.57–2.44 | |||
Preoperative BMI (≤ 24.2) | 2.97 | 0.014 | 1.24–7.11 | 1.44 | 0.482 | 0.52–4.07 |
Comorbidity Index (≤ 2.0) | 1.18 | 0.665 | 0.56–2.52 | |||
Tumor site (Larynx) | 0.26 | 0.001 | 0.12–0.56 | 0.84 | 0.753 | 0.28–2.54 |
T1-T2 vs. T3-T4a | 1.98 | 0.140 | 0.80–4.88 | |||
N- vs. N+ | 0.45 | 0.036 | 0.21–0.95 | 0.66 | 0.396 | 0.26–1.71 |
Pharyngeal reconstruction (No) | 0.18 | <0.001 | 0.08–0.40 | 0.90 | 0.900 | 0.19–4.40 |
Salivary tube (No) | 1.11 | 0.847 | 0.37–3.23 | |||
Salvage surgery (No) | 0.58 | 0.171 | 0.27–1.26 | |||
PORT (No) | 0.88 | 0.741 | 0.41–1.88 | |||
Class. (continuous) | 1.82 | <0.001 | 1.40–2.37 | 1.57 | 0.085 | 0.94–2.64 |
PCF (No) | 0.77 | 0.490 | 0.36–1.63 | |||
Short-term complications (No) | 0.45 | 0.051 | 0.20–1.00 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Grasl, S.; Schmid, E.; Heiduschka, G.; Brunner, M.; Marijić, B.; Grasl, M.C.; Faisal, M.; Erovic, B.M.; Janik, S. A New Classification System to Predict Functional Outcome after Laryngectomy and Laryngopharyngectomy. Cancers 2021, 13, 1474. https://doi.org/10.3390/cancers13061474
Grasl S, Schmid E, Heiduschka G, Brunner M, Marijić B, Grasl MC, Faisal M, Erovic BM, Janik S. A New Classification System to Predict Functional Outcome after Laryngectomy and Laryngopharyngectomy. Cancers. 2021; 13(6):1474. https://doi.org/10.3390/cancers13061474
Chicago/Turabian StyleGrasl, Stefan, Elisabeth Schmid, Gregor Heiduschka, Markus Brunner, Blažen Marijić, Matthaeus Ch. Grasl, Muhammad Faisal, Boban M. Erovic, and Stefan Janik. 2021. "A New Classification System to Predict Functional Outcome after Laryngectomy and Laryngopharyngectomy" Cancers 13, no. 6: 1474. https://doi.org/10.3390/cancers13061474
APA StyleGrasl, S., Schmid, E., Heiduschka, G., Brunner, M., Marijić, B., Grasl, M. C., Faisal, M., Erovic, B. M., & Janik, S. (2021). A New Classification System to Predict Functional Outcome after Laryngectomy and Laryngopharyngectomy. Cancers, 13(6), 1474. https://doi.org/10.3390/cancers13061474